✦ LIBER ✦

516 Impact of Entecavir Versus Lamivudine on Hepatic Covalently Closed-Circular DNA and Total Hepatic HBV DNA in Nucleoside-NaïVE HBeAg Positive Chronic Hepatitis B Patients

✍ Scribed by Bowden, Scott; Locarnini, Stephen; Chang, Ting-Tsung; Chao, You-Chen; Han, Kwang-Hyub; Gish, Robert G.; De Man, Robert A.; Llamoso, Cyril; Tang, Hong

Book ID: 123350181
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 481 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63532-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

759 IMPACT OF ENTECAVIR VERSUS LAMIVUDIN

759 IMPACT OF ENTECAVIR VERSUS LAMIVUDINE ON HEPATIC COVALENTLY CLOSED-CIRCULAR DNA AND TOTAL HEPATIC HBVDNA IN NUCLEOSIDE-NAÏVE HBeAg POSITIVE CHRONIC HEPATITIS B PATIENTS

✍ Bowden, S.; Locarnini, S.; Chang, T.-T.; Chao, Y.-C.; Han, K.-H.; Gish, R.G.; de 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Loss of HBsAg antigen during treatment w

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

✍ R. G. Gish; T.-T. Chang; C.-L. Lai; R. De Man; A. Gadano; F. Poordad; J. Yang; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Results of up to 2 years of entecavir vs

Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

✍ T.-T. Chang; Y.-C. Chao; V. V. Gorbakov; K.-h. Han; R. G. Gish; R. De Man; H. Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Impact of Intrahepatic Hepatitis B DNA a

Impact of Intrahepatic Hepatitis B DNA and Covalently Closed Circular DNA on Survival After Hepatectomy in HBV-Associated Hepatocellular Carcinoma Patients

✍ Qin Wang PhD, M. Isabel Fiel MD, Wei Luan MD, Sima Blank MS, Hena Kadri BS, Ki W 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 344 KB

Prediction of response to entecavir ther

Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels

✍ J. W. Shin; S. W. Jung; B. R. Park; C. J. Kim; J. B. Eum; B. G. Kim; I. D. Jeong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

The impact of HBV-DNA fluctuations on vi

The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine

✍ J. Gotto; G. J. M. Webster; D. Brown; J. Jenkins; G. M. Dusheiko; A. Bertoletti 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB